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Abstract Chronic pancreatitis continues to be a major therapeutic challenge for
all pancreatic surgeons. This article is written with a purpose to review various
surgical procedures developed from time to time for the relief of pain in these
patients. Since no single procedure can be labeled as ‘‘ideal’’ because of the prob-
lems of the inability to address the whole pathology at the initial procedure, failure
or recurrence of the pain; most of the pancreatic and practicing surgeons may ben-
efit from knowledge of the various procedures being performed, even though the
personal experience of the surgeon most of the time ultimately dictates the final
choice of the procedure for the patient.
ª 2006 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.Introduction
It was Rufus of Ephesus (c. 100AD) who named the
organ ‘‘Pancreas’’ (in Greek Pan: all, Kreas: Flesh
or meat). Then it was Homer who used the word
‘‘sweetbread’’ broadly to describe animal flesh.1
This organ with the name sweetbread, however,
turns quite bitter as soon it develops the patholog-
ical condition called Chronic pancreatitis.
Chronic pancreatitis has been defined as a con-
tinuing inflammatory disease of the pancreas
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that typically cause pain and or permanent loss of
function.2e4 An ideal classification system for
chronic pancreatitis would be simple, objective, ac-
curate, incorporating etiology, pathogenesis, struc-
ture, function and clinical status into one overall
scheme. Although these criteria have never been
met, several systems have been advocated. The
most widely used classification systems includes
Marseille classification of 19633e5 with revisions in
19846 and 19887 and the Cambridge classification
of 1984.8,9 The Cambridge system proves more use-
ful as a staging system once the diagnosis has been
established. The most recent Marseille-Rome classi-
fication 19887 includes more causal factors but
proves to be more useful in defining rather thann behalf of Surgical Associates Ltd.
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dence and prevalence of chronic pancreatitis have
increased markedly probably due to the changes in
alcohol consumption and improved sensitivity of
diagnostic tests. Early series from Copenhagen,10
the U.S.11 and Mexico City12 reported a similar inci-
dence of about 4 per 100,000 inhabitants per year
and prevalence rate of 45.5 per 100,000 in males
and 12.4 per 100,000 in females.13 Recent advances
in techniques and genetics provide possibilities for
early and accurate identification of risk factors
leading to chronic pancreatitis. Chronic pancre-
atitis has been categorized into toxic, idiopathic,
genetic, autoimmune, recurrent attacks of acute
pancreatitis and obstructive (TIGAR-O risk factor
classification system version 1). The classification
is based on prevalence of each etiological factor
and has implications for potential treatment.14
The inflammatory component of chronic pancrea-
titis is incurable and conventional treatment strate-
gies are directed towards palliation and management
ofcomplications.Medicalmanagementwhichconsists
of enzyme replacement, control of diabetes with
insulin and oral analgesics is generally effective,
although eventually one third of the patients will
need surgery during the course of their disease.
The surgical management of pancreatitis has
seen its ups and downs over the past few decades.
The risks of pancreatic surgery were initially high
but a few surgeons were bold enough to approach
the chronically inflamed and enlarged pancreas. A
number of surgical procedures have been developed
during the 20th century to deal with the condition.
Review of literature indicates the maximum effi-
cacy of any procedure to be 85e90%. There is no
procedure evolved to provide a 100% cure for the
condition.15 Therefore surgery is aimed at control-
ling pain and managing complications rather than
halting the progression of the disease. An appropri-
ate and effective procedure has been difficult to
devise and at the moment there is no clear ‘‘market
leader’’ operation and the choice depends up on
a grey zone where in pathological picture, patient’s
condition and available expertise dictate the final
procedure the patient undergoes.
The ideal procedure for treating pain in chronic
pancreatitis should be the one which is simple,
easy to perform, associated with low morbidity
and mortality, and at the same time should provide
adequate drainage and not augment endocrine and
exocrine insufficiency.
Indications for surgical intervention
Currently the following are considered the accept-
able indications for surgery.161. Intractable pain.
2. Suspicion of malignant neoplasm.
3. Non-resolving ductal stenosis.
4. Non-resolving common bile duct stenosis.
5. Pseudo-aneurysms or vascular erosions not
controlled by radiological intervention.
6. Endoscopically not controlled large pseudo-
pancreatic cyst.
7. Intractable internal pancreatic fistula.
Preoperative evaluation and patient
selection
Once a patient has been selected to undergo
surgery for pain relief, a thorough preoperative
evaluation must be performed. Two important
questions must be answered.
1. Will this patient benefit most from a decom-
pression of the pancreatic ductal system or
from resection of pancreas?
2. Is this patientharboringa pancreaticmalignancy?
The various biochemical and radiological tests
for preoperative assessment and diagnosis are as
follows.
Blood tests
Elevations of serum amylase and lipase are found
helpful during acute attacks of pain. In the later
stages chronic pancreatitis atrophy of the pancre-
atic parenchyma can result in serum enzyme levels
within the reference range, even during acute
exacerbations.
While low levels of serum trypsin are specific for
advanced chronic pancreatitis, they are not sensi-
tive enough to be helpful in most patients with
mild to moderate disease.17
Laboratory studies to identify causative factors
include serum calcium and triglyceride levels.
Fecal tests
Steatorrhoea may be present in advanced
chronic pancreatitis but neither qualitative nor
quantitative fecal fat analysis can detect early
disease.
Direct tests
Tests to detect chronic pancreatitis early are
invasive and expensive.
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Pancreatic secretions are stimulated by exogenous
secretion to achieve maximal output. The bicar-
bonate, protease, amylase and lipase output is
then measured in the duodenal aspirates. This test
is, however, only available in specialized centers.
Determination in pancreatic juice
This test is performed at the time of endoscopic
retrograde pancreatography (ERCP). The pancre-
atic duct is freely cannulated, an external secre-
tagogue is administered and the pancreatic juice is
then aspirated out of the duct as it is produced.
The bicarbonate, protease, amylase and lipase
output is then measured. This test is gaining
popularity because most patients undergo ERCP
during the evaluation of chronic pancreatitis.
Indirect test
Non-invasive tests in principle work via oral ad-
ministration of a complex substance that is hydro-
lyzed by a specific pancreatic enzyme to release
a marker substance. The marker is then absorbed
by the intestine and in turn measured in the serum
or urine. These tests are capable of detecting
moderate to severe degrees of chronic pancre-
atitis. Liver, renal and intestinal disease may
interfere with the interpretation of these tests.
They are not freely available in the United
States.17e19
Imaging studies
Structural changes in the pancreas and its ductal
system are only seen during the moderate and
severe stages of the disease, so most imaging pro-
cedures cannot depict early chronic pancreatitis.
Abdominal radiograph
Pancreatic calcification is observed in 30% of cases.
They first form in the head and then in body and tail.
Paired anterposterior and oblique views are pre-
ferred because the vertebral column may otherwise
obscure small specks of calcification.
Computerized tomography
Although CT excels at depicting the morphological
changes of advanced chronic pancreatitis, the early
changes are beyond its resolution and a normal
finding on this study does not rule out chronic
pancreatitis. CT is most useful to identify compli-
cations and in planning surgical or endoscopic
intervention.17Endoscopic retrograde pancreatography
(ERCP)
ERCP provides the most accurate visualization of
the pancreatic ductal system and has been re-
garded as the criterion standard for diagnosing
chronic pancreatitis. Conversely one limitation of
ERCP is that it cannot be used to evaluate the
pancreatic parenchyma, and histologically proven
chronic pancreatitis has been documented in the
setting of normal pancreatogram. The pancreato-
gram can be classified according to several
schemes such as Cambridge criteria.
A comparison of pancreatogram scoring with
direct pancreatic function tests demonstrates good
correlation. However, pancreatography tended to
show more significant severe changes. ERCP is
invasive, expensive, requires complete opacifica-
tion of the pancreatic duct to visualize sidebranches
and carries a risk of pancreatitis.17,20,21
Magnetic resonance
cholangiopancreatography (MRCP)
MRCP imaging provides information on the pancre-
atic parenchyma and adjacent abdominal viscera
and uses heavily T2 weighted images to visualize
the biliary and pancreatic ductal system. The use
of secretin during the procedure enhances the
quality to enable the diagnosis of early chronic pan-
creatitis; however, it is relatively safe, reasonably
accurate, non-invasive, fast and very useful in plan-
ning surgical and endoscopic intervention.17,22,23
Endoscopic ultrasound (EUS)
EUS may be the best test for imaging the pancreas as
per the recent studies. By placing the transducer
immediately adjacent to the pancreas, the endo-
scopic approach eliminates the interference by bowel
gas and enables the use of high frequency probes to
enable acquisition of detailed imaging. Eleven sono-
graphic criteria have been developed that identify
characteristic findings of chronic pancreatitis. Using
these criteria EUS correlates well with endoscopic
pancreatic ductography and intra-ductal secretin
tests in moderate and severe disease. EUS may be
useful in diagnosing chronic pancreatitis in a subset of
patient with non-ulcer dyspepsia. More experience is
required to determine its utility in detecting the early
stages of chronic pancreatitis.17,20
Other tests
A secretin stimulated ultrasound study is one way
of looking for the resistance to pancreatic juice
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of the pancreatic duct is measured at baseline and
then 15 and 30 min after injection of secretin.
Dilatation to a diameter greater than normal or
for a longer period implies the presence of peri-
ampullary stricture or papillary stenosis.17,20
What is the most appropriate
procedure?
The choice of surgical procedure depends upon the
indication for surgery and the characteristics of
disease in the individual patient. In general it is
most appropriate to select a procedure which is
likely to achieve the maximum symptomatic pain
relief and also maximally preserve the functional
pancreatic tissue.
Drainage procedures were developed on the basis
that the pain in chronic pancreatitis is due to ductal
hypertension24 and proper drainage could decom-
press it. On the other hand the theories of perineu-
ral inflammation as the cause of pain lead to the
development of resectional procedures.25
A. Drainage procedure,
1. Partial: draining the duct partially,
a. Sphincterotomy and sphincteroplasty,
b. Duval procedure,
c. Puestow Gillesby procedure,
d. Leger’s procedure,
e. Marcadier procedure,
2. Complete: draining the main duct
completely,
I. Pancreaticojejunostomy,
a. PartingtoneRochelle procedure,
b. Bapat’s modification of Partington’s
procedure,
II. Pancreaticogastrostomy,
a. Moreno Gonzales procedure.
B. Resectional procedures,
a. Whipple’s operation,
b. TraversoeLongmire procedure,
c. Begaris procedure,
d. Denervated pancreatic flap,
Warrens denervated pancreatic flap,
Shires denervated splenopancreatic flap,
e. Subtotal pancreatic resection,
f. Childs procedure,
g. Total pancreatectomy,
With duodenal preservation,
Without duodenal preservation.
C. Extended drainage procedure,
a. Rumpf’s extended drainage.
D. Resection with extended drainage,
a. Extended Begar’s procedure,b. Frey’s procedure,
c. Izbicki V shaped ventral pancreatic excision.
E. Pancreatic denervation alone,
a. Left splanchnicectomy with celiac gang-
lionectomy,
b. Left splanchnicectomy, celiac ganglionectomy
with bilateral vagotomy,
c. Complete pancreatic denervation,
d. Transthoracic/videothoracoscopic pancreatic
denervation,
F. Pancreatic auto-transplantation,
a. Islet cell transplantation,
b. Segmental pancreatic transplantation.
Drainage procedures
These drainage procedures proved pain relief in
up to 60e80% cases.15
Partial drainage procedures
Sphincterotomy and sphincteroplasty
Transduodenal sphincterotomy was originally pro-
posed by Doubilet and Mulholland for the treat-
ment of chronic pancreatitis with the mistaken
belief that the disease was caused by bile reflux.26
The operation did not prove effective and subse-
quent attempts to improve pancreatic drainage
by dividing the septum between the bile duct
and the pancreatic duct have not proved popu-
lar.27 In chronic pancreatitis it is unusual to find
a uniformly dilated duct obstructed at the termi-
nation only therefore it follows that these proce-
dures are unlikely to prove successful; however,
early success rates of 50%26,27 when pain relief
was assessed at 5 years have not been sustained.28
Although surgical sphincterotomy has largely been
given up; similar procedures have been recently
performed endoscopically with enthusiasm.29
Duval procedure
Decompression of the main pancreatic duct is
achieved by resection of the pancreatic tail and
retrograde drainage of the pancreatic duct via
a termino-lateral pancreaticojejunostomy (Fig. 1).
However, this procedure will only be effective if
there is a single stricture between pancreatic tail
and the ampulla of Vater which in most of the
cases is unlikely.30,31
Puestow Gillesby procedure
They recommend a longitudinal opening of the
pancreatic duct from the site of the transaction of
the duct after resection of the pancreatic tail and
spleen to a point to the right of the mesenteric
vessels and invagination of the open duct with
pancreas into a Roux-en-Y loop of jejunum, thus
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(Fig. 2). This procedure takes care of multiple
strictures seen in chronic pancreatitis.31,32
Leger’s procedure
This procedure developed for distal strictures
involves a 40% distal pancreatectomy with sple-
nectomy followed by opening of the pancreatic
duct into a loop of jejunum by a retrograde lateral
pancreaticojejunostomy.33
Mercadier procedure
Here only the body of the pancreas is drained into
a Roux-en-Y loop of jejunum by a side to side
anastomosis.15
Partial drainage procedures have been aban-
doned because of the small anastomosis which
tends to occlude. Also the concept of preservation
of the spleen with pancreatic tail is important as it
Figure 1 The Duval procedure.
Figure 2 The Puestow Gillesby procedure.prevents post-splenectomy sepsis34 and delays the
onset of diabetes mellitus.35
Complete drainage procedures
Pancreaticojejunostomy
PartingtoneRochelle procedure. This procedure
is a refined Puestow procedure. It consists of a side
to side long pancreaticojejunostomy, at least 10 cm
without, resection of the pancreatic tail or the pan-
creas. However, a dilated main pancreatic duct
(minimum 8 mm) is a prerequisite for a good duct
to mucosa anastomosis.36 In one of the largest se-
ries Greenlee37 reported significant improvement
in 82% of there patients with lateral pancreaticoje-
junostomy with an extended follow up of up to 25
years. Similar results have been reported by
others.33,38 In our experience, this procedure has
been performed on more than 90 patients of
chronic pancreatitis with a duct size of more than
7 mm since 1985 till date. We strongly are in favour
of this procedure in any patient with a duct size of
more than 7 mm because of the technical ease, low
morbidity, and excellent long-term results. We ob-
served significant long-term improvement in more
than 80% of our patients operated at SKIMS.
Bapat’s procedure. It is modification of Part-
ington’s procedure. Here the pancreatic duct is
opened from head to tail with wide drainage by
a side to end pancreaticojejunostomy after fish
mouthing the jejunal end to a required length. A
duct to mucosa anastomosis is performed. Again
the prerequisite is a dilated duct of at least 7 mm.
This procedure is more physiological and ensures
a straight conical dependent anastomosis with
effective and complete drainage.39
Pancreaticogastrostomy
Pancreaticogastrostomy has been advocated by
some to be a better form of drainage procedure
than pancreaticojejunostomy.40 The procedure is
performed as a mucosa to mucosa anastomosis
over a T tube. A pain relief of up to 79% has
been reported41; however, more patients devel-
oped steatorrhoea because of the inactivation of
the pancreatic enzymes by gastric acid. However,
most surgeons still regard pancreaticojejunostomy
as the drainage operation of choice.
Moreno Gonzales procedure. Pancreatic and
bile duct drainage is established into an isolated
vascularised loop of jejunum which is then anas-
tomosed to the duodenum. The procedure has
potential advantages, it allows the return of bile
and pancreatic secretions into the duodenum and
there is no pancreaticocibal asynchrony.38
In conclusion the patients with ductal dilatation
of more than 7e8 mm, no inflammatory mass or
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cess are the most suitable candidates for lateral
pancreaticojejunostomy. The results of pancre-
aticojejunostomy are difficult to interpret. Many
reports have differing indications, different forms
of surgery and inadequate follow up. In general
however, all forms of drainage procedures tend
to worsen over time especially if patients do not
abstain from alcohol.42
Resectional procedures
The head is considered to be pacemaker of the
disease and its complications. A mass in the pan-
creatic head is found in 30e60% of the patients with
chronic pancreatitis.43,44 No study has yet conclu-
sively shown pain being only attributable to main
duct obstruction and it is difficult to think of
a good reason to believe so. The pathogenesis of
pain is most likely not only related to ductal and
parenchymal hypertension but also to the theory
of perineural inflammation.25 In addition lateral
pancreaticojejunostomy never drains the second
and third order pancreatic ducts, hence the concept
led to the development of resectional procedures.
Whipple’s operation (1935)
The procedure although first described by Allen O
Whipple in 1912, but published much later for
malignant lesions of the head of the pancreas is
now also used for benign inflammatory mass in
the head with a non-dilated pancreatic duct. The
procedure consists of a pancreaticoduodenectomy
with reconstruction by a pancreaticojejunostomy/
gastrostomy, gastrojejunostomy and choledochoje-
junostomy. This is a complex and technically chal-
lenging procedure with higher mortality rates as
compared to drainage procedure, however, with
good results. This procedure involves excising nor-
mal organs much against the principles of surgery
for a benign disorder and has given way to more
conservative approaches.45 However, it is the pre-
ferred surgical option if there is any suspicion of ma-
lignancy, as in such a situation there should be no
compromise on the radicality of the procedure.
TraversoeLongmire procedure
Originally used in 1994 for a peri-ampullary tumor
by Watson,46 it was subsequently used by Traversoe
Longmire for chronic pancreatitis in 1978.47 As
a gastrectomy is avoided and the pylorus and the
proximal duodenum are preserved it achieves
a better postoperative nutritional status, mini-
mizes postgastrectomy syndromes as well as the
incidence of marginal ulceration. For thesereasons it has almost become the form of resection
for patients requiring pancreaticoduodenectomy
in chronic pancreatitis.
Recent reports on pancreaticoduodenectomy for
chronic pancreatitis have recorded a low mortality
rate of 0e1%, significant pain relief of 80e100%.48e50
The incidenceofdiabetes increased from 17 to44% in
the preoperative period to 26e64% in the postopera-
tive period.48,51,52 However, the onset of diabetes on
follow up rather than immediately after the surgery
suggests progression of the disease rather than the
effect of surgery.
Hans Begar’s procedure
This procedure is indicated in chronic pancreatitis
with inflammatory mass in the head with medically
intractable pain, obstruction of the common bile
duct, duodenal stenosis or portal hypertension due
to compression of portal vein by inflammatory
mass. It is a duodenum sparing resection of the
head of the pancreas thus preserving duodenal
physiology and normal intestinal continuity which
has significance in terms of postoperative nutri-
tional status, blood sugar control and marginal
ulceration. Two major steps are involved:
Resection: The pancreas is transected at the
border between the head and the body above the
superior mesenteric vein leaving a small disk of
the head between the common bile duct and the
duodenal wall.
Drainage: The body of the pancreas is drained
by an end to end pancreaticojejunostomy and
the pancreatic head by a side to side anastomosis
to the rim of the resection cavity.53e55
The procedure seems to be safe with perioper-
ative mortality of 0e0.8%. Significant relief of pain
has been reported in 86e92% of patients.56e59 It is
not associated with fresh development of diabetes
in the early postoperative period. However, exist-
ing diabetes may worsen in 10e13% of the
patients.56,58 However, late diabetes develops in
21% of the patients due to progression of the
disease. DPPHR when compared to PPPD has a su-
perior outcome because of better pain control,
weight gain, better glucose tolerance and higher
insulin secretion capacity.43
Denervated pancreatic flaps
In Warrens procedure the pancreas is divided over
the portal superior mesenteric vein after ligation
of the splenic artery and vein. The pancreatic head
is excised leaving a thin rim. The remaining
pancreas is not drained. Ligation of splenic vein
and artery is presumed to denervate the gland.60
Shires et al. described a more elaborate pro-
cedure called a denervated splenopancreatic flap
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procedure includes complete mobilization of the
pancreas from the retroperitoneum, resection of
the head and the uncinate process leaving a small
rim near the duodenum, division of the splenic
vein near its junction with the superior mesenteric
vein and drainage of the distal pancreatic remnant
into a Roux-en-Y limb of jejunum. The complexity
of the procedure and its unproven efficacy may
limit its usefulness.
Subtotal pancreatic resection
Excision of the body and distal pancreas used to be
a commonly performed procedure during 1960e1970
but with the development of better imaging facilities
it was noted that disease in the body and the tail is
often secondary to disease in the head of the
pancreas, thereby limiting its role. This procedure
is still indicated when the disease is confined to the
body and tail e.g., pseudocyst, failed pancreatico-
jejunostomy, non-dilated duct, pseudo-aneurysm
and when there is suspicion of a malignant lesion in
the body and tail. Here up to 80% of the distal
pancreas is resected beyond the neck of pancreas,
and the pancreatic duct is closed. A concomitant
splenectomy is unavoidable in the majority of pa-
tients because of dense fibrosis precluding the iso-
lation of the splenic vessels. However, splenic
preservation may be possible in 20e34% of pa-
tients.62e64 Another procedure described by Warsaw
in which splenic salvage is achieved by preservation
of the short gastric vessels early mortality is 0e
4%63e64 and pain relief is 70e88%.65,66 About 20% de-
velop diabetes in the early postoperative period.
Severe hypoglycemic coma and brain damage occur
in 2e4% of all such patients.64 Further an increased
incidence of steatorrhoea is seen in 15%.66
Childs resection
This procedure first described by Barret and
Bowers in 195767 was popularized by Child. It is
a 95% distal pancreatectomy. The spleen, the
tail, body and uncinate processes are completely
removed. The small cuff of the head that is pre-
served protects the vascularity and common bile
duct during surgery. This procedure is performed
when lesser procedures have failed or when the
entire pancreas is severely diseased.68 Pain relief
is about 90% with a mortality of up to 4%64,65 while
diabetes develops in 50% of patients64 and the in-
cidence of early steatorrhoea increases by 30%.66
Total pancreatectomy
Total pancreatectomy bringing in its wake perma-
nent endocrine and exocrine deficiency is usuallyoffered as a last resort to patients with chronic
pancreatitis who have diffuse involvement of the
pancreas with non-dilated ducts, suspicion of
malignancy or failed previous procedure. The
operative mortality ranges from 0 to 10%48,63,66e72
and pain relief is achieved in 80%.66
In the absence of counter regulatory hormones
control of sugar is very difficult (brittle diabetes).
Hypoglycemic attacks after total pancreatectomy
can lead to death or irreversible brain damage.
Patients who are already insulin dependent and
need pancreatic supplementation for steatorrhoea
are ideally suited for this procedure.
Duodenum preserving total pancreatectomy
Russel in 1987 reported a total pancreatectomy
with duodenal preservation. The operative pro-
cedure is extremely tedious; pain relief is achieved
in 75e80% of patients and no postoperative deaths
have been reported. Early complications include
bleeding, sepsis and duodenal fistula. However, at
a later stage patients may develop bile duct or
duodenal stricture. This procedure is also offered
as a last report as is total pancreatectomy.73,74
Extended drainage procedures
Rumpf’s extended drainage procedure
This is a combination of Partington’s procedure
with a transduodenal pancreatic sphincteroplasty.
It is indicated when there is a pre-papillary
obstruction to the drainage of pancreatic duct
due to stones or stricture.75
Resection with extended drainage
The reported incidence of inflammatory mass in
the head is about 30% of which only 10% are
malignant.76 Resection with extended drainage
procedure provides cure in up to 95% of cases.77
Extended Begar’s procedure
In cases where there are multiple strictures in the
leftpancreaswithan inflammatorymass in thehead,
this procedure has a superior result (Figs. 3 and 4). In
addition to the duodenum preserving head resection
a side to side pancreaticojejunostomy is performed
after slitting open the main pancreatic duct.
Frey’s procedure
A modified procedure combining lateral pancreati-
cojejunostomy of PartingtoneRochelle with coring
out of the pancreatic head (overlying the ducts of
Wirsung and Santorini and the uncinate process)
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tissue posterior and medially (Fig. 5). If the duct is
less than 8 mm in size mucosa to capsule anastomo-
sis is performed. This procedure is indicated for pain
in chronic pancreatitis with its complications like
pseudocyst, common bile duct obstruction, pancre-
atic ascites, fistulae and recurrent pain after lateral
pancreaticojejunostomy. It is contraindicated in
patients where cancer cannot be excluded.78,79
Izbicki’s ‘‘V’’ shaped ventral pancreatic
excision
In this procedure a long ‘‘V’’ shaped excision of
ventral aspect of the pancreas is done with a lateral
pancreaticojejunostomy by a mucosa to capsule
anastomosis. This procedure drains the main as well
as the second and third order ducts. This is an ideal
procedure for small duct disease with a maximum
diameter of the Wirsung’s duct less than 3 mm.80
Pancreatic denervation alone
Splanchnic nerves and the sympathetic trunks in-
dicate pain arising from the pancreas, extrahepatic
biliary ducts and gastrointestinal tract from the
level of the stomach to the rectosigmoid. Interest
in surgical neurectomy has progressed by the
observation that fibers which mediate pancreatic
pain interconnect only through the celiac and
superior mesenteric plexus. Various methods of
deneravation have been described.
Left splanchnicectomy with celiac
ganglionectomy with or without vagotomy
Mallet Guy advocated an extra peritoneal ap-
proach through the 12 ribs for left splanchnicec-
tomy with celiac ganglionectomy.81 This is done
after correcting the extra pancreatic pathology.
Figure 3 The Partington Rochelle procedure.In a 5-year follow up of these patients there was
an 84% overall improvement. However, the failure
rate was up to 31% in patients with diffuse pancre-
atic fibrosis and no discernable extra pancreatic
Figure 4 The Begar’s procedure.
Figure 5 The Extended Begar’s procedure.
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is unclear. Generally however, bilateral vagotomy
is considered to increase the completeness of pan-
creatic denervation.
Complete pancreatic denervation
Hirokawa described a more extensive denervation
procedure, which includes freeing the pancreas
from the posterior abdominal wall and resection of
all postganglionic pancreatic nerve plexus includ-
ing those surrounding the common hepatic and
splenic arteries.83 Follow up is short, probably this
procedure may provide a reasonable alternative to
extensive resection.
Transthoracic/videothoracoscopic
pancreatic denervation
There are important thoracic anatomical consider-
ations regarding the innervation to the pancreas. The
greater splanchnic nerves are largely responsible for
pain in supramesentric viscera and the nerve trunks
lie above the level of the 10th thoracic vertebra and
descend along the spine to end in the celiac plexus,
similarly the lesser splanchnic plexus. Transthoracic
denervation can be achieved by division of the
splanchnic nerves with bilateral vagotomy per-
formed through a left thoracotomy. A similar pro-
cedure is now performed using a videothoracoscopic
technique.84 This minimally invasive procedure
achieved results almost equal to those of major ab-
dominal surgery. Follow up of 12 months demon-
strated an improved quality of life. This procedure
may be considered for patients who do not meet an-
atomic criteria for drainage and those who may not
be candidates for major abdominal surgery.
Pancreatic auto-transplantation
Although subtotal and total pancreatectomies
successfully alleviate the pain of chronic pancre-
atitis, patients develop troublesome insulin de-
pendent diabetes mellitus. This can be overcome
auto-transplantation.
Islet cell auto-transplantation
The Mirkowitch technique which is used to prepare
partially purified islets produces a fairly large volume
of minced digested islet cell tissue which is then
injected into a portal vein. Despite slow injection
portal pressure is markedly raised several fold.
Hinshaw et al. developed and tested a more sophis-
ticated islet preparation technique. This technique
produced a 5 ml tissue pellet containing 500,000e
2000,000 islets for transplantation,85 no problems
were noted with this preparation and the portalpressure remained essentially unchanged. Long-
term success (insulin independence) with both these
techniques is reported at 40e43%.85,86
Segmental pancreatic transplantation
This technique comprises auto-transplantation of
the resected body and tail of the pancreas into the
thigh following near total pancreatectomy. The
splenic vessels are anastomosed to the femoral
vessels. The divided end of the pancreas is closed
and the duct is ligated87 or injected with synthetic
polymers (e.g., prolamine or neoprene). Duct oblit-
eration is thought to cause rapid and permanent at-
rophy of the exocrine pancreas and preserves
endocrine function.88 However, others concluded
that duct obliteration does not prevent relapse or
progression of chronic pancreatitis in the preserved
pancreatic segment.89 Internal drainage of the duct
into a Roux-en-Y limb of jejunum has also been re-
ported with good results.90 Technical success was
achieved in up to 80% of patients with pain relief
in 80% and insulin independence in 70%.87
Ruling out a malignant neoplasm
There is evidence to suggest that chronic pancre-
atitis could predispose to pancreatic malignancy.91
Studies show that the risk rises with duration from
1.8% at 10 years to 4% at 20 years and it has been
speculated that it is due to the increased levels of
growth factors92; another report showed a 6% ma-
lignant change of inflammatory head mass at 9
years follow up.56 Concomitant malignancy has
been reported in 15e21% of patients undergoing
surgery for chronic pancreatitis which may be de-
tected at surgery or on follow up.93 Differentiating
a malignant neoplasm in the head of the pancreas
from an inflammatory mass of chronic pancreatitis
is a major challenge for the surgeon which needs
to be addressed at the time of surgery. The head
in chronic pancreatitis is hard and enlarged so
the hope of detecting carcinoma by palpation is
not possible and is only an illusion. A 15% error in
sampling as well as interpretation makes frozen
section an unreliable tool to exclude malignancy.94
Therefore a high degree of suspicion is to be enter-
tained in these patients. In such situation only re-
section probably pancreaticoduodenectomy should
be preferred as any lesser procedure may leave
behind the lesion or cause tumor spillage.
Control of complications
Associatedcomplicationsofadjacentorgans resultng
from chronic pancreatitis like CBD and duodenal
obstruction with gastric outlet obstruction require
54 N.A. Wani et al.bypass procedures or resection of the inflammatory
mass. Frequently, there bypass procedures become
necessary after lateral pancreaticojejunostomy.
With pylorus preserving resections these additional
procedures are not required. This safely and effec-
tively combines thecontrol of complications with the
preservation of original anatomy and thus is a more
physiological procedure.
The relevance of segmental portal hypertension
in a patient of chronic pancreatitis is poorly
understood. Complications of segmental portal
hypertension are rare and its presence should not
influence the choice of operation.
Complications such as internal fistula, pseudo-
cysts, pancreatico-portal fistula, or pseudo-
aneurysm require an individualized approach.
Conclusion
The old controversy ‘‘resection or drainage’’ is
probably now irrelevant. Both have established
roles and probably best results are achieved by
a combination of both. Chronic pancreatitis is such
a complex and variegated disease that there is
never a single procedure that would achieve goals
in all patients. Therefore, it is important to un-
derstand that the choice of surgery has to be
individualized to address the pathological change
in each patient. However, ultimately it is the
surgeons experience and an operative strategy
that is slightly modified for every patient that is
going to achieve the best possible results and that
is what would be ultimately an ideal or somewhat
close to ideal procedure for chronic pancreatitis.
However, most of the operative procedures de-
scribed in this monogram need a larger series of
treated patients to be followed to adopt a de-
finitive and probably better future strategy for
managing this complex problem.
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